U.S. and international medical organizations recommend against testing children for genetic diseases that occur after adolescence and for which no prevention or treatment is available.
Supporters of reproductive choice believe that women receive inadequate information about prenatal testing—often after some testing has already been done.
While some argue that live footage of emergency room treatment is beneficial to the general public, the AMA's Code of Medical Ethics states that such taping is a violation of patient privacy and patient confidentiality.
Presymptomatic genetic testing for neurodegenerative diseases can help patients make effective treatment decisions, but the medical profession needs to ensure that the increasing use of the tests is done responsibly.
Retainer practices set an example to medical students and other providers that the highest level of physician satisfaction is available only to those who serve the wealthy.
Douglas E. Paull, MD, MS and Paul N. Uhlig, MD, MPA
Risk managers can help patient-subjects and clinician-researchers make informed novel device implantation decisions in the absence of preclinical trial data.
AMA J Ethics. 2020;22(11):E911-918. doi:
10.1001/amajethics.2020.911.